Encyclopedia of Clinical Neuropsychology

2018 Edition
| Editors: Jeffrey S. Kreutzer, John DeLuca, Bruce Caplan

Doxepin

  • Efrain Antonio GonzalezEmail author
Reference work entry
DOI: https://doi.org/10.1007/978-3-319-57111-9_1652

Generic Name

Doxepin

Brand Name

Sinequan and Silenor

Class

Tricyclic antidepressants

Proposed Mechanism(s) of Action

Doxepin is hypothesized to be a potent serotonin and norepinephrine reuptake inhibitor. Histamine 1 blockade.

Indication

Depression, anxiety, depression associated with alcohol, depression or anxiety associated with organic disease, psychotic depression with anxiety, manic depression, and insomnia.

Off-Label Use

Itching, lichen simplex chronicus, anxiety, insomnia, neuropathic pain, and treatment-resistant depression.

Side Effects

Dry mouth, constipation, blurred vision, headache, agitation, insomnia, anxiety, nausea, vomiting, sweating, confusion, dizziness, and orthostasis.

Serious

Paralytic ileus, hyperthermia, lowered seizure threshold, sudden death, cardiac arrhythmias, tachycardia, QTc prolongation, hepatic failure, mania, potential for activation of suicidal ideation.

Common

Blurred vision, constipation, urinary retention, increased appetite, dry mouth, diarrhea,...

This is a preview of subscription content, log in to check access.

References and Reading

  1. Physicians’ Desk Reference. (71st ed.). (2017). Montvale: Thomson PDR.Google Scholar
  2. Stahl, S. M. (2007). Essential psychopharmacology: The prescriber’s guide (2nd ed.). New York: Cambridge University Press.Google Scholar

Additional Information

  1. Free Drug Online and PDA Software. www.epocrates.com.
  2. Free Drug Online and PDA Software. www.medscape.com.

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.College of PsychologyNova Southeastern UniversityFort LauderdaleUSA
  2. 2.Utah State UniversityLoganUSA